by Frederique Ponchel, Ann W. Morgan, Sarah J

Slides:



Advertisements
Similar presentations
Retrovirally Transduced CD34++ Human Cord Blood Cells Generate T Cells Expressing High Levels of the Retroviral Encoded Green Fluorescent Protein Marker.
Advertisements

a b c Figure S1 Figure S1: Gating strategy describing T cell subsets.
Alvin Y. Liu, Martine P. Roudier, Lawrence D. True 
Figure e-1A.
Plasmacytoid dendritic cells efficiently cross-prime naive T cells in vivo after TLR activation by Juliette Mouriès, Gabriel Moron, Géraldine Schlecht,
Combination therapy for adult T-cell leukemia–xenografted mice: flavopiridol and anti-CD25 monoclonal antibody by Meili Zhang, Zhuo Zhang, Carolyn K. Goldman,
Characterization of a rare IL-10–competent B-cell subset in humans that parallels mouse regulatory B10 cells by Yohei Iwata, Takashi Matsushita, Mayuka.
Selective expansion of polyfunctional pathogen-specific CD4+ T cells in HIV-1–infected patients with immune reconstitution inflammatory syndrome by Yolanda.
by Jacob Rachmilewitz, Gregory J
by Masih Ostad, Margareta Andersson, Astrid Gruber, and Anne Sundblad
by Shawn W. Cochrane, Ying Zhao, Robert S. Welner, and Xiao-Hong Sun
Thymocyte Fas Expression Is Dysregulated in Myasthenia Gravis Patients With Anti-Acetylcholine Receptor Antibody by Nathalie Moulian, Jocelyne Bidault,
Defective B-cell-negative selection and terminal differentiation in the ICF syndrome by Carla E. Blanco-Betancourt, Anne Moncla, Michèle Milili, Yun Liang.
The TCL1 oncoprotein inhibits activation-induced cell death by impairing PKCθ and ERK pathways by Gilles Despouy, Marjorie Joiner, Emilie Le Toriellec,
by Jennifer Huggins, Tina Pellegrin, Raymond E
Impaired function of human T-lymphotropic virus type 1 (HTLV-1)–specific CD8+ T cells in HTLV-1–associated neurologic disease by Amir H. Sabouri, Koichiro.
by Silke Huber, Reinhard Hoffmann, Femke Muskens, and David Voehringer
DUSP4-mediated accelerated T-cell senescence in idiopathic CD4 lymphopenia by Alexandre Bignon, Alexis Régent, Laurence Klipfel, Aude Desnoyer, Pierre.
Ubiquitous high-level gene expression in hematopoietic lineages provides effective lentiviral gene therapy of murine Wiskott-Aldrich syndrome by Alexander.
A B Untreated MM1 15 mM GRN163L 15mM
Volume 135, Issue 6, Pages (December 2008)
by Norman Nausch, Ioanna E
Novel function for interleukin-7 in dendritic cell development
CD300a is expressed on human B cells, modulates BCR-mediated signaling, and its expression is down-regulated in HIV infection by Rodolfo Silva, Susan Moir,
Distinct but phenotypically heterogeneous human cell populations produce rapid recovery of platelets and neutrophils after transplantation by Alice M.
Altered Homeostasis of CD4+ Memory T Cells in Allogeneic Hematopoietic Stem Cell Transplant Recipients: Chronic Graft-versus-Host Disease Enhances T Cell.
Sequential Polarization and Imprinting of Type 1 T Helper Lymphocytes by Interferon-γ and Interleukin-12  Edda G. Schulz, Luca Mariani, Andreas Radbruch,
Primitive quiescent leukemic cells from patients with chronic myeloid leukemia spontaneously initiate factor-independent growth in vitro in association.
by Carlos Márquez, César Trigueros, Jaime M. Franco, Almudena R
Maraviroc contributes to the restoration of the homeostasis of regulatory T-cell subsets in antiretroviral-naive HIV-infected subjects  M.M. Pozo-Balado,
Expansion of CD7low and CD7negative CD8 T-cell effector subsets in HIV-1 infection: correlation with antigenic load and reversion by antiretroviral treatment.
Preformed CD40 ligand exists in secretory lysosomes in effector and memory CD4+ T cells and is quickly expressed on the cell surface in an antigen-specific.
W.H. Abdulahad, Y.M. van der Geld, C.A. Stegeman, C.G.M. Kallenberg 
In vivo T-cell dynamics during immune reconstitution after hematopoietic stem cell gene therapy in adenosine deaminase severe combined immune deficiency 
Skin-Resident Effector Memory CD8+CD28– T Cells Exhibit a Profibrotic Phenotype in Patients with Systemic Sclerosis  Gang Li, Adriana T. Larregina, Robyn.
Elucidation of the EP defect in Diamond-Blackfan anemia by characterization and prospective isolation of human EPs by Deena Iskander, Bethan Psaila, Gareth.
Volume 33, Issue 1, Pages (July 2010)
Different ploidy levels of megakaryocytes generated from peripheral or cord blood CD34+ cells are correlated with different levels of platelet release.
by Vladia Monsurrò, Ena Wang, Yoshisha Yamano, Stephen A
Unique Abnormalities of CD4+ and CD8+ Central Memory Cells Associated with Chronic Graft-versus-Host Disease Improve after Extracorporeal Photopheresis 
CD11c+ dendritic cells and plasmacytoid DCs are activated by human cytomegalovirus and retain efficient T cell-stimulatory capability upon infection by.
Comparison of primary human cytotoxic T-cell and natural killer cell responses reveal similar molecular requirements for lytic granule exocytosis but differences.
Elevated Numbers of Immature/Transitional CD21− B Lymphocytes and Deficiency of Memory CD27+ B Cells Identify Patients with Active Chronic Graft-versus-Host.
FLT3 ligand administration after hematopoietic cell transplantation increases circulating dendritic cell precursors that can be activated by CpG oligodeoxynucleotides.
Regulatory T cells differentially modulate the maturation and apoptosis of human CD8+ T-cell subsets by Maria Nikolova, Jean-Daniel Lelievre, Matthieu.
by Ulrike Schleicher, Andrea Hesse, and Christian Bogdan
Figure 3 Decreased AHI1 in human CD4+ T cells is associated with decreased proliferation and increased IFNγ production Decreased AHI1 in human CD4+ T cells.
Onset of thymic recovery and plateau of thymic output are differentially regulated after stem cell transplantation in children  Matthias Eyrich, Gernot.
Volume 140, Issue 1, Pages e3 (January 2011)
Volume 137, Issue 5, Pages (November 2009)
Volume 15, Issue 4, Pages (October 2001)
Volume 35, Issue 5, Pages (November 2011)
Increased, but Functionally Impaired, CD14+ HLA-DR–/low Myeloid-Derived Suppressor Cells in Psoriasis: A Mechanism of Dysregulated T Cells  David C. Soler,
TCF1 expression marks self-renewing human CD8+ T cells
Volume 28, Issue 6, Pages (June 2008)
Protective Immunity Transferred by Infusion of Cytomegalovirus-Specific CD8+ T Cells within Donor Grafts: Its Associations with Cytomegalovirus Reactivation.
Volume 16, Issue 5, Pages (May 2002)
CD25 expression distinguishes functionally distinct alloreactive CD4+ CD134+ (OX40+) T-cell subsets in acute graft-versus-host disease  Philip R Streeter,
Volume 80, Issue 2, Pages (July 2011)
Volume 17, Issue 2, Pages (February 2009)
Heterogeneity of mast cells and T cells in the nasal mucosa
Functional analysis of clinical response to low-dose IL-2 in patients with refractory chronic graft-versus-host disease by Jennifer S. Whangbo, Haesook.
Common Developmental Pathway for Primitive Erythrocytes and Multipotent Hematopoietic Progenitors in Early Mouse Development  Toshiyuki Yamane, Aya Washino,
Volume 21, Issue 6, Pages (December 2004)
John B Reppas, W.Martin Usrey, R.Clay Reid  Neuron 
Volume 15, Issue 4, Pages (October 2001)
Machteld M. Tiemessen, Tracey J. Mitchell, Lisa Hendry, Sean J
Volume 22, Issue 3, Pages (March 2005)
Rapid immune reconstitution of SCID-X1 canines after G-CSF/AMD3100 mobilization and in vivo gene therapy by Olivier Humbert, Frieda Chan, Yogendra S. Rajawat,
IL-9–expressing TH cells are highly enriched in CCR4+/CCR8+ effector memory TH cells. IL-9–expressing THcells are highly enriched in CCR4+/CCR8+effector.
Presentation transcript:

Dysregulated lymphocyte proliferation and differentiation in patients with rheumatoid arthritis by Frederique Ponchel, Ann W. Morgan, Sarah J. Bingham, Mark Quinn, Maya Buch, Robert J. Verburg, Judy Henwood, Susan H. Douglas, Aurelie Masurel, Philip Conaghan, Moji Gesinde, Julia Taylor, Alexander F. Markham, Paul Emery, Jacob M. van Laar, and John D. Isaacs Blood Volume 100(13):4550-4556 December 15, 2002 ©2002 by American Society of Hematology

T-cell differentiation subsets in RA patients and healthy controls T-cell differentiation subsets in RA patients and healthy controls.(A) Atypical differentiation in RA patients. T-cell differentiation subsets in RA patients and healthy controls.(A) Atypical differentiation in RA patients. Representative flow cytometry plots of a healthy control (57-year-old man) and a patient with RA (42-year-old woman) are shown. CD4+ T cells were isolated by negative selection using magnetic beads. Cell surface staining was performed with antibodies against CD45RB, CD45RA, CD45RO, and CD62L. CD45RBbright cells are plotted as green throughout and CD45RBdull cells as pink. Naive cells are defined by the expression of CD45RBbright, CD45RA+, and CD62L+, as indicated by the ellipses. Memory cells are defined as CD45RBdull, CD45RA−, and CD45ROhigh, as indicated by the square. Compared with the healthy control, the RA patient has a smaller naive population, CD45RBdull CD45RA+CD62L+ cells (dotted ellipse in control) are absent, and various atypical subsets have appeared (asterisk, hexagon, and arrows; see text for details). In RA patients, a significant proportion of CD45RA+ cells are also CD45RObright. (B) Naive and memory CD4+ T cells in RA patients. Total lymphocytes were recovered from a panel of healthy controls and RA patients. CD4+ T cells were separated and analyzed as described, and the proportion of naive and memory cells were plotted against age. ♦ indicate healthy controls; ⋄, patients with early RA; ▵, patients with resistant RA. Statistical analysis: controls, age versus naive T-cell proportion, r = −0.930,P < .0001; age versus memory T-cell proportion,r = +0.865, P < .0001. RA patients (both groups combined): age versus naive T-cell proportion,r = −0.480, P = .002. RA patients: age versus memory T-cell proportion, r = +0.295,P = .016. Frederique Ponchel et al. Blood 2002;100:4550-4556 ©2002 by American Society of Hematology

TREC content of CD4+ T cells is decreased in RA patients TREC content of CD4+ T cells is decreased in RA patients.(A) TREC content of total CD4+ T cells is decreased in RA patients. TREC content of CD4+ T cells is decreased in RA patients.(A) TREC content of total CD4+ T cells is decreased in RA patients. CD4+ T cells were negatively selected using magnetic beads, and DNA was extracted from the enriched population. TREC content was measured by real-time PCR. Controls (♦) are compared with RA patients (⋄, early RA; ▵, resistant RA). CD4+T-cell TREC content in RA patients was lower than in healthy controls (P < .0001). TREC content decreased with age in both groups (controls, r = −0.816, P < .0001; RA, r = −0.229, P = .132). (B) TREC content of naive CD4+ T cells is lower in RA patients. Naive CD4+ T cells were sorted by flow cytometry (on the basis of their CD45RBbright, CD45RA+, CD62L+ phenotype) from total CD4+ T cells. TREC content was measured as above. Controls (♦) are compared with RA patients (⋄, early RA; ▵, resistant RA). In contrast to total TREC values, there was no significant relationship between the TREC content of naive T cells and age. TREC content of naive T cells in RA patients remained significantly different from that in controls (P < .0001). TREC content was lower in early and resistant RA groups than in controls (controls vs early patients,P = .014; controls vs resistant patients,P < .0001). There was also a significant difference in TREC content between patients with early and resistant RA (P = .005). Frederique Ponchel et al. Blood 2002;100:4550-4556 ©2002 by American Society of Hematology

TREC content of naive CD4+ T cells correlates negatively with CRP and CRP correlates positively with circulating naive and atypical CD4 ± T cells.(A) Cross-sectional study. TREC content of naive CD4+ T cells correlates negatively with CRP and CRP correlates positively with circulating naive and atypical CD4 ± T cells.(A) Cross-sectional study. TREC content of naive CD4+ T cells was plotted against CRP for RA patients, illustrating a negative correlation (r = −0.750,P < .0001). (B) Longitudinal study. Longitudinal data from a patient with RA (24-year-old woman) with fluctuating disease severity. CRP (▪) and TREC content of naive (CD45RBbright CD45RA+ CD62L+) CD4+ T cells (⋄) are negatively correlated, whereas CRP and atypical (CD45RBbright CD45RA+CD62L−) cell counts (▵) are positively correlated. (C) Cross-sectional study. The proportion of circulating CD4+ T-cells of naive (♦) and atypical (⋄) phenotype was determined as described in Figure 1 and plotted against CRP. There was a positive correlation between CRP and frequency of atypical cells (r = +0.537, P < .0001) and a weaker correlation with the frequency of naive cells (r = +0.366,P = .017). Frederique Ponchel et al. Blood 2002;100:4550-4556 ©2002 by American Society of Hematology

Atypical T cells are the progeny of naive T cells Atypical T cells are the progeny of naive T cells.CD4+ T cells were isolated by negative selection, and cell surface staining was performed for CD45RB, CD45RA, CD45RO, and CD62L. Atypical T cells are the progeny of naive T cells.CD4+ T cells were isolated by negative selection, and cell surface staining was performed for CD45RB, CD45RA, CD45RO, and CD62L. Cells were sorted according to their expression of CD45RO and then of CD45RB, CD45RA, and CD62L. DNA was extracted from the subsets illustrated, and TREC content was measured by real-time PCR. Results from 3 healthy controls (22, 33, and 57 years old) and from 3 patients with early RA (45, 61, and 62 years old) were pooled. Values are normalized to the naive cell TREC content of each person. Subsets dominant in healthy controls are shown by solid bars, and atypical subsets dominant in RA patients are shown by hatched bars. Results represent the mean and SD of 3 independent experiments. Frederique Ponchel et al. Blood 2002;100:4550-4556 ©2002 by American Society of Hematology

Activation threshold is lower in atypical cells than in naive cells Activation threshold is lower in atypical cells than in naive cells.CD4+ T cells were separated, and naive and atypical subsets were sorted from 50 mL blood. Activation threshold is lower in atypical cells than in naive cells.CD4+ T cells were separated, and naive and atypical subsets were sorted from 50 mL blood. Proliferation was assessed in response to PHA (0.01-10 μg/mL; Sigma) or anti-CD3 (OKT3, 0.01-1 μg/mL) with or without anti-CD28 (YTH913.12, 5 μg/mL) antibodies. Proliferation was quantified by the incorporation of 3H-thymidine (1 μCi/well) after 5 days of culture and was normalized to cells in medium only. Results represent the means and SD of independent experiments using 5 RA patients. Frederique Ponchel et al. Blood 2002;100:4550-4556 ©2002 by American Society of Hematology

Model for T-cell differentiation in healthy controls and patients with RA.The models are based on flow cytometry data (Figure 1) and TREC content of individual subsets (Figure 4). Model for T-cell differentiation in healthy controls and patients with RA.The models are based on flow cytometry data (Figure 1) and TREC content of individual subsets (Figure 4). Each subset is represented by a box. White boxes represent subsets found in healthy controls, and gray boxes represent subsets found predominantly in RA patients. Subsets are characterized as TREC rich, TREC high, TREC intermediate (int), and TREC poor, in relation to other subsets from the same pathway (ie, health or RA). In healthy controls we have proposed 2 pathways, culminating in conventional and central memory T cells. In RA, there is proliferation, differentiation, or both within the naive subset, indicated by a circular arrow, resulting in the appearance of atypical subsets that are TREC high. The conventional memory pathway can still be identified, but the central memory pathway cannot. Atypical CD45RBdull CD45RA− CD45RO−CD62L+ cells are also present. Frederique Ponchel et al. Blood 2002;100:4550-4556 ©2002 by American Society of Hematology